Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65924 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(R)-(+)-Verapamil-d6 Hydrochloride
CAS:Controlled ProductFormula:C27H32D6N2O4•HClColor and Shape:Off-WhiteMolecular weight:460.6536469-Desmethyl endo-Granisetron Hydrochloride
CAS:Controlled Product<p>Impurity Granisetron USP Related Compound C<br>Stability Hygroscopic<br>Applications 9-Desmethyl endo-Granisetron hydrochloride (Granisetron USP Related Compound C) is an impurity in the synthesis of Granisetron HCl (G780000), a specific serotonin (5HT3) receptor antagonist. Used as an antiemetic.<br>References Kilpatrick, G.J., et al.: Nature, 330, 746 (1987), Durig, T., et al.: J. Pharm. Sci., 86, 1092 (1997), Yuasa, H., et al.: Chem. Pharm. Bull., 44, 1361 (1996),<br></p>Formula:C17H22N4O·ClHColor and Shape:NeatMolecular weight:334.841-Nitroso-4-phenylpiperazine
CAS:Controlled Product<p>Applications Metabolite of N-Phenylpiperazine (P336040) found in wastewater treatment facilities.<br>References Jung, C. et al., Appl. Environ. Microb., 74, 6147 (2008)<br></p>Formula:C10H13N3OColor and Shape:NeatMolecular weight:191.23Safinamide-d4
CAS:Controlled Product<p>Applications Safinamide-d4 is a labelled analogue of Safinamide. Safinamide is a potent and selective MAO-B inhibitor, and is used as an add-on treatment to treat Parkinson’s disease.<br>References Finberg, J.P.M., et al.: Front Pharmacol., 7, 340-54 (2016);<br></p>Formula:C17D4H15FN2O2Color and Shape:NeatMolecular weight:306.3685-Fluoro-3-(4-piperidinyl)-1,2-benzisoxazole Hydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An intermediate of 5-Fluoro Risperidone (F595925).<br>References Strupczewski, J.T., et al.: J. Med. Chem., 28, 761 (1985),<br></p>Formula:C12H13FN2O·ClHColor and Shape:NeatMolecular weight:256.70Oxo-MDV 3100 (Oxo-enzalutamide)
CAS:Controlled Product<p>Applications Oxo-MDV 3100 (Oxo-enzalutamide) is an impurity of Enzalutamide (M199800), which is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. Enzalutamide has been shown to induce tumor cell apoptosis, and is used for the treatment of castration-resistant prostate cancer.<br>References Scher, H.I. et al.: Lancet, 375, 1437 (2010); Bellmunt, J. et al.: Ther. Adv. Med. Oncol., 2, 189 (2010); Ryan, C.J. et al.: J. Clin. Oncol., 29, 3651 (2011); Ma, X., et al.: J. Pharm. Biomed. Anal., 131, 436 (2016);<br></p>Formula:C21H16F4N4O3Color and Shape:NeatMolecular weight:448.372-Amino-5-cyanobenzotrifluoride
CAS:Controlled Product<p>Applications 2-Amino-5-cyanobenzotrifluoride is used in the design and synthesis of 4-phenylpyrrole derivatives as androgen receptor antagonists which show efficacy against prostate cancer cells.<br>References Yamamoto, S. et al.: Bioorg. Med. Chem. Lett., 20, 422 (2012), Chen, J. et al.: Synth. Met., 160, 1953 (2010);<br></p>Formula:C8H5F3N2Color and Shape:NeatMolecular weight:186.1339Erismodegib
CAS:Controlled Product<p>Applications A potent, selective and orally bioavailable Smoothened (SMO) antagonist; it inhibits hedgehog (Hh) signaling pathway via antagonism of the Smoothened receptor (SMO). Antineoplastic. Potent Hedgehog inhibitor.<br>References Berman, D., et al.: Science, 297, 1559 (2002), Varjosalo, M., et al.: Cell, 133, 537 (2008), Theunissen, J., et al.: Cancer Res., 69, 6007 (2009),<br></p>Formula:C26H26F3N3O3Color and Shape:NeatMolecular weight:485.504-Amino-2-fluoro-N-methylbenzamide
CAS:Controlled Product<p>Stability Moisture Sensitive<br>Applications 4-Amino-2-fluoro-N-methylbenzamide acts as a reagent in the design, synthesis and biological evaluation of novel 5-oxo-2-thioxoimidazolidine derivatives as potent androgen receptor antagonists. Also, in the preparation and structure-activity relationship of chiral benzyloxypyridinone derivatives as c-Met kinase inhibitors<br>References Ivachtchenko, A. V., et al.: Eur. J. Med. Chem., 99, 51 (2015); Zhang, D., et al.: Bioorg. Med. Chem. Lett., 23, 2408 (2013)<br></p>Formula:C8H9FN2OColor and Shape:NeatMolecular weight:168.17(S)-4-Hydroxy Propranolol Hydrobromide
CAS:Controlled Product<p>Applications (S)-4-Hydroxy Propranolol is the main metabolite of (S)-Propranolol (P831795).<br>References Shwed, J., et al.: Xenobiotica, 22, 973 (1992), Fujita, K., et al.: Biol. Pharm. Bull., 22, 446 (1999), Walle, U., et al.: Drug Metab. Dispos., 30, 564 (2002),<br></p>Formula:C16H21NO3·ClHColor and Shape:NeatMolecular weight:311.803-Hexyl Chloroformate (>80%)
CAS:<p>Stability Air Sensitive, Moisture Sensitive<br>Applications 3-Hexyl Chloroformate is a potential impurity in the synthesis of Dabigatran Etexilate Mesylate (D100150); a nonpeptide and direct thrombin inhibitor. Antithrombotic.<br>References Zheng, Y., et al.: Org. Process Res. Dev., 18, 744 (2014); Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002); Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002); Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005)<br></p>Formula:C7H13ClO2Purity:>80%Color and Shape:NeatMolecular weight:164.634-(6-Nitro-3-pyridinyl)-1-nitroso-piperazine
CAS:Controlled ProductFormula:C9H11N5O3Color and Shape:NeatMolecular weight:237.215(R)-Desmethyl Citalopram Hydrochloride
CAS:Formula:C19H19FN2O·ClHColor and Shape:NeatMolecular weight:346.834-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine
CAS:Controlled Product<p>Applications 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine is a reagent in the synthesis of (+)-tofacitinib, a selective Janus kinase 3 inhibitor (JAK3) and an immunosuppressant drug.<br>References Liao, H., et al.: Tetrahedron: Asymmetry, 28, 105, (2017)<br></p>Formula:C13H10ClN3O2SColor and Shape:NeatMolecular weight:307.76Dimenhydrinate
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An antihistamine with antiemetic properties used to prevent nausea and motion sicknes composed of two drugs 8-Chlorotheophylline (C411440) and Diphenhydramine (D486900).<br>References Sibel, K. et al.: Arzneim.-Forsch. , 52, 529 (2002); Pytel, J. et al.: Clin. Therap., 29, 84 (2007); Scholtz, A.W. et al.: Clin. Therap., 26, 866 (2004);<br></p>Formula:C17H21NO·C7H7ClN4O2Color and Shape:NeatMolecular weight:469.96N-Denitroso-N’-nitroso Lomustine-d4
CAS:Controlled ProductFormula:C9D4H12ClN3O2Color and Shape:NeatMolecular weight:237.72Olanzapine Lactam Impurity
CAS:<p>Impurity Olanzapine ketolactam impurity<br>Applications A degradation product of Olanzapine (LY170053) (O253750) in solid oral formulations.<br>References Chakrabarti, J., et al.: J.Med. Chem., 25, 1133 (1982), Chafetz, L., et al.: J. Pharm. Sci., 73, 1186 (1984), Hartauer, K., et al.: Pharm. Dev. Technol., 5, 303 (2000),<br></p>Formula:C17H20N4O2Color and Shape:NeatMolecular weight:312.375-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid
CAS:Controlled Product<p>Applications Sunitinib intermediate.<br></p>Formula:C16H13FN2O3Color and Shape:NeatMolecular weight:300.28Desmethoxy Apixaban
CAS:<p>Applications Desmethoxy Apixaban is an impurity of Apixaban; an anticoagulant drug.<br>References Landge, S. B., et al.: Am. J. Anal. Chem., 6, 539 (2015); Arous, B., et al.: Pharm. Chem. J. 52, 573 (2018)<br></p>Formula:C24H23N5O3Color and Shape:NeatMolecular weight:429.471Ethyl 2-[N-[(2'-Cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate
CAS:<p>Applications Ethyl 2-[N-[(2'-Cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate is a useful reagent in synthesis of candesartan cilexitil.<br>References Zhu, Y., et al.: Zhongguo Yaowu Huaxue Zazhi, 13, 31 (2003); Cao, R., et al.: Zhongguo Yiyao Gongye Zazhi, 34, 425 (2003);<br></p>Formula:C23H19N3O4Color and Shape:NeatMolecular weight:401.414'-(Bromomethyl)-[1,1'-biphenyl]-2-carboxamide
CAS:Controlled Product<p>Impurity Telmisartan Bromo Amide Impurity<br>Applications An impurity in the preparation of the angiotensin II receptor antagonist Telmisartan (T017000).<br>References Wienen, W., et al.: Brit. J. Pharmacol., 110, 245 (1993), Neutel, J.M., and Smith, D.H.G.: Adv. Ther., 15, 206 (1998)<br></p>Formula:C14H12BrNOColor and Shape:WhiteMolecular weight:290.16OPC 3930
CAS:Controlled Product<p>Applications A metabolite of Cilostazol (C441500), used as internal standard.<br>References Akiyama, H., et al.: Arzneim.-Forsch./Drug Res., 35, 1133 (1985), Akiyama, H., et al.: J. Chromatogr., 338, 456 (1985),<br></p>Formula:C19H23N5O2Color and Shape:NeatMolecular weight:353.422-(2,4-Difluorophenyl)-1,2,3-propanetriol
CAS:<p>Applications 2-(2,4-Difluorophenyl)-1,2,3-propanetriol is used as a reagent in the synthesis of glycerol derivatives as intermediates for antifungal phenyltriazolylpropanediol derivatives. Also an impurity of the antifungal agent Fluconazole (F421000).<br>References Richard, K. et al.: Antimicrob. Ag. Chemother., 27, 832 (1985); Yasohara, Y., et al.: PCT Int. Appl. WO 9528374 A1 19951026. Oct 26, 1995<br></p>Formula:C9H10F2O3Color and Shape:NeatMolecular weight:204.17N-Desethyl N-Methyl rac-Rivastigmine
CAS:<p>Impurity Rivastigmin USP Related Compound B<br>Applications N-Desethyl N-Methyl rac-Rivastigmine (Rivastigmin USP Related Compound B) is an impurity in the synthesis of Rivastigmine (R541000) a brain selective acetylcholinesterase inhibitor. Nootropic.<br>References Rosler, M., et al.: Brit. Med. J., 318, 633 (1999), Enz, A., et al.: Prog. Brain Res., 98, 431 (1993),<br></p>Formula:C13H20N2O2Color and Shape:Clear ColourlessMolecular weight:236.31N-[(1S,2S,4S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic Acid 5-Thiazolylmethyl Ester
CAS:Controlled Product<p>Impurity Ritonavir EP Impurity J<br>Applications N-[(1S,2S,4S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]carbamic Acid 5-Thiazolylmethyl Ester (Ritonavir EP Impurity J) is an intermediate in the synthesis of Ritonavir (R535000), a selective HIV protease inhibitor used for the treatment of HIV infections and AIDS.<br>References Hamada, Y., et al.: Bioorg. Med. Chem., 10, 4155 (2002);<br></p>Formula:C28H35N3O5SColor and Shape:White To Off-WhiteMolecular weight:525.664-(Trifluoromethoxy)aniline
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 4-(Trifluoromethoxy)aniline is used in the synthesis of anticancer agents and antitumor medicaments. Also, its an intermediate in the production of labelled Riluzole (R510000), a neuroprotective agent. Modulates glutamatergic transmission. A glutamate release inhibitor. An anticonvulsant.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Cilibrizzi, A., et al.: J. Med. Chem., 52, 5044 (2009), Verhaeghe, P., et al.: Bioorg. Med. Chem., 17, 4313 (2009), Chandregowda, V., et al.: Eur. J. Med. Chem., 44, 3046 (2009), Wahl, F., et al.: Eur. J. Pharmacol., 230, 209 (1993) Bensimon, G., et al.: N. Engl. J. Med., 330, 585 (1994); Piras, S. et al.: Eur. j. Med. Chem., 75, 169 (2014); Vyas, V. et al.: Eur. J. Med. Chem., 82, 385 (2014);<br></p>Formula:C7H6F3NOColor and Shape:NeatMolecular weight:177.12Sitagliptin N-Sulfate Sodium Salt
CAS:Controlled Product<p>Applications A metabolite of Sitagliptin.<br>References Beconi, M.G. , et al.: Drug Metab. Dispos., 35, 525 (2007),<br></p>Formula:C16H15F6NaN5O4SColor and Shape:NeatMolecular weight:509.36Quetiapine Carboxylate Impurity
CAS:Controlled Product<p>Applications Quetiapine Carboxylate is an impurity of Quetiapine Hemifumarate (Q510000), an atypical antipsychotic agent used for the treatment of patients with schizophrenia, biopolar disorder and to treat major depressive disorder.<br>References Wetzel, H., et al.: Psychopharmacol., 119, 231 (1995); Bharathi, C., et al.: Pharmazie., 63, 14 (2008);<br></p>Formula:C22H25N3O4SColor and Shape:Light Orange ColourMolecular weight:427.52Apatinib-d8 25-N-Oxide Dihydrochloride
CAS:Controlled Product<p>Applications Labelled Apatinib 25-N-Oxide (A726160). Apatinib 25-N-Oxide is a metabolite of the antiangiogenic agent and selective VEGFR2 inhibitor Apatinib (A726150).<br>References Ding, J, et al.: J. Chrom B Anal. Technol. Biomed. Life Sci., 895, 108 (2012);<br></p>Formula:C24H15D8N5O2•2HClColor and Shape:NeatMolecular weight:421.52236462,6-Dichloro-7-deazapurine
CAS:Controlled ProductFormula:C6H3Cl2N3Color and Shape:NeatMolecular weight:188.015,7-Difluorochroman-4-one
CAS:Controlled ProductFormula:C9H6F2O2Color and Shape:NeatMolecular weight:184.14(Z)-4-Hydroxy Tamoxifen O-β-D-Glucuronide (~90%)
CAS:Controlled Product<p>Applications (Z)-4-Hydroxy Tamoxifen O-β-D-Glucuronide is an active metabolite of Tamoxifen (T006000).<br>References Ogura, K. et al.: Biochem. Pharmacol., 71, 1358 (2006); Nishiyama, T. et al.: Biochem. Pharmacol., 63, 1817 (2002); McCague, R. et al.: Biochem. Pharmacol., 39, 1459 (1990);<br></p>Formula:C32H37NO8Purity:~90%Color and Shape:NeatMolecular weight:563.64N-tert-Butyl-3-isopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide
CAS:Controlled Product<p>Applications N-tert-Butyl-3-isopropyl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-1-carboxamide is a metabolite of Amicarbazone (A605040); a triazolinone herbicide with a broad spectrum of weed control.<br>References Dayan, F., et al.: Weed Science, 57, 579 (2009); Elmore, M., et al.: Weed Technol., 27, 596 (2013); Dong, M., et al.: J. Sep. Sci., 38, 2245 (2015)<br></p>Formula:C10H18N4O2Color and Shape:White To Off-WhiteMolecular weight:226.28Nintedanib 4-Nitrophenyl 2-(4-Nitroso)
Controlled ProductFormula:C13H17N5O4Color and Shape:NeatMolecular weight:307.305Anastrozole EP Impurity E (2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile)
CAS:Controlled Product<p>Impurity Anastrozole EP Impurity E<br>Applications 2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile (Anastrozole EP Impurity E ) is an impurity of Anastrozole (A637425), an aromatase inhibitor which functions as an antineoplastic (1,2). Anastrozole is used in post-menopausal women with advanced breast cancer.<br>References 1. Plourde, P. et al.: Breast Cancer Res Treat. 1994;30(1):103-112. Buzdar, A. et al.: Cancer. 1997 Feb 15;79(4):730-9.<br></p>Formula:C15H18N2OColor and Shape:NeatMolecular weight:242.32Deacetyl Racecadotril Disulfide
CAS:Controlled Product<p>Applications Deacetyl Racecadotril Disulfide is an impurity of Racecadotril (R070600); an antidiarrheal and enkephalinase inhibitor that reduces the amount of water and electrolytes into the intestine.<br>References Cezard, J., et al.: Gastroenterol., 120, 799 (2001); Sato, T., et al.: J. Med. Chem., 51, 7705 (2008); Lakshmana, P., et al.: J. Pharm. Res., 8, 39 (2009); Fournie-Zaluski, Marie Claude., et al.: J. Med. Chem., 35(13), 2473-81 (1992)<br></p>Formula:C38H40N2O6S2Color and Shape:NeatMolecular weight:684.86cis-Hydroxy Solifenacin N-Oxide(Mixture of Diastereomers)
Controlled Product<p>Applications Solifenacin (S676700) metabolite.<br></p>Formula:C23H26N2O4Color and Shape:NeatMolecular weight:394.46(S)-3-(Boc-amino)piperidine
CAS:Controlled Product<p>Applications Useful intermediate for the synthesis of a variety of chiral aminopiperidinyl quinolones as potent antibacterial agents against resistant pathogens; and alkynylpyrimidine amide derivatives as orally available inhibitors of Tie-2 kinase.<br>References Hu, X., et al.: J. Med. Chem., 46, 3655 (2003), Cee, V., et al.: J. Med. Chem., 50, 627 (2007),<br></p>Formula:C10H20N2O2Color and Shape:NeatMolecular weight:200.28t-Butyl 4-Bromobutanoate
CAS:Controlled Product<p>Applications t-Butyl 4-bromobutanoate is a useful research chemical for organic synthesis and other chemical and pharmaceutical processes.<br>References Brudeli, B., et al.: Bioorg. Med. Chem., 18, 8600 (2010); Colak, S., et al.: Macromolecules, 41, 8436 (2008)<br></p>Formula:C8H15BrO2Color and Shape:NeatMolecular weight:223.11Homopiperazine
CAS:Controlled Product<p>Applications Homopiperazine acts as a corrosion inhibitor for iron. It has also been used in the preparation of potent H3 receptor antagonists for use as treatments for neurodegenerative conditions such as Alzheimer’s disease.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Granese, S. et al.: Corrosion., 44, 322 (1988); Pippel, D. et al.: Org. Proc. Res. Devel., 15, 638 (2011);<br></p>Formula:C5H12N2Color and Shape:NeatMolecular weight:100.16Nintedanib Demethyl-O-glucuronic Acid
CAS:Formula:C36H39N5O10Color and Shape:NeatMolecular weight:701.721-Benzo[b]thien-4-yl-piperazine Monohydrochloride
CAS:Controlled Product<p>Applications 1-Benzo[b]thien-4-yl-piperazine is the starting material to prepare piperazine-substituted benzothiophenes useful in treatment and prevention of mental disorders including CNS disorders.<br>References Yamashita, H., et al.: PCT Int. Appl., WO 2006112464 A1 20061026 (2006)<br></p>Formula:C12H14N2S·ClHColor and Shape:NeatMolecular weight:254.78Agomelatine-d3 (acetamide-2,2,2-d3)
CAS:Controlled Product<p>Applications Agomelatine-d3 (acetamide-2,2,2-d3) (CAS# 1079389-38-0) is a useful isotopically labeled research compound.<br></p>Formula:C15D3H14NO2Color and Shape:NeatMolecular weight:246.321-Ethyl-2-[(methylamino)methyl]pyrrolidine
CAS:<p>Applications 1-Ethyl-2-[(methylamino)methyl]pyrrolidine is an intermediate of the neuroleptic drug Amisulpride (A633250).<br>References Tahara, T., et al.: Chem. Pharmaceut. Bull., 38, 1609 (1990);<br></p>Formula:C8H18N2Color and Shape:Colourless OilyMolecular weight:142.242Methyl 3,4,5-Tris(benzyloxy)benzoate
CAS:Controlled Product<p>Applications Intermediate in the production of Gallic Acid derivatives.<br>References Dodo, K., et al.: Bioorg. Med. Chem., 16, 7975 (2008), Dodo, K., et al.: Chem. Pharm. Bull., 57, 190 (2009),<br></p>Formula:C29H26O5Color and Shape:NeatMolecular weight:454.516-(4-Phenylbutoxy)-1-hexanamine
CAS:<p>Applications 6-(4-Phenylbutoxy)-1-hexanamine is an intermediate in the synthesis of salmeterol (S090100), a structural analog of Albuterol (A514500).<br>References Goswami, J., et al.: Tetrahedron. Asym., 12, 3343 (2002);<br></p>Formula:C16H27NOColor and Shape:Off White SolidMolecular weight:249.39S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil
CAS:Controlled Product<p>Applications S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil is an impurity of Vardenafil (V098001, 2HCl); a selective phosphodiesterase type 5 (PDE5) inhibitor.<br>References Bischoff, E., et al.: J. Urol., 165, 1316 (2001); Kim, N.N., et al.: Life Sci., 69, 2249 (2001); Kendirci, M., et al.: Expert Opin. Pharmacother., 5, 923 (2004)<br></p>Formula:C21H26N6O7SColor and Shape:Off White SolidMolecular weight:506.53(S)-(-)-Felodipine
CAS:Controlled Product<p>Applications A dihydropyridine calcium channel blocker. Enantiomer S of Felodipine.<br>References Berntsson, P.B., et al.: Acta Pharm. Suec., 18, 221 (1981), Kratochwil, N., et al.: Biochem. Pharmacol., 64, 1355 (2002), O'Brien, S., et al.: J. Med. Chem., 48, 1287 (2005), Castilho, M., et al.: Bioorg. Med. Chem., 14, 516 (2006),<br></p>Formula:C18H19Cl2NO4Color and Shape:White To Off-WhiteMolecular weight:384.25Trazodone 1,4-Di-N-Oxide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A possible metabolite of Trazodone-HCl (T718500).<br></p>Formula:C19H22ClN5O3Color and Shape:NeatMolecular weight:403.866,8-Dioxo Apalutamide
CAS:Controlled Product<p>Applications 6,8-Dioxo Apalutamide is an impurity of Apalutamide (A726120). Apalutamide is a second-generation antiandrogen used in the treatment of prostate cancer.<br>References Li, Huifang, et al.: J. of Chem. Info. and Model., 53(1), 123-130 (2013);Joseph, James D., et al.: Cancer Disc., 3(9), 1020-1029 (2013)<br></p>Formula:C21H15F4N5O3Color and Shape:NeatMolecular weight:461.38Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)
CAS:Formula:C47H46N12O3Color and Shape:Off-WhiteMolecular weight:826.95rac-7-Oxo-pramipexole Dihydrochloride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications An impurity of Pramipexole production.<br>References Jancic, B., et al.: Acta Chim. Slov., 54, 49 (2007),<br></p>Formula:C10H17Cl2N3OSColor and Shape:NeatMolecular weight:225.31 + 2(36.46)β-Tetralone
CAS:Controlled Product<p>Applications β-Tetralone is the 2-keto derivative of Tetralin. β-Tetralone was initially reported to be a metabolite of Tetralin but was later found to be just an artifact in the metabolism process. β-Tetralone is known to be biological marker in fossil fuels.<br>References Elliott, T.H. et al.: Biochem. J., 108, 551 (1968); Armstrong, D. et al.: Microchem. J., 57, 149 (1997);<br></p>Formula:C10H10OColor and Shape:NeatMolecular weight:146.19(R)-(+)-Felodipine
CAS:Controlled Product<p>Applications A dihydropyridine calcium channel blocker. Enantiomer R of Felodipine.<br>References Berntsson, P.B., et al.: Acta Pharm. Suec., 18, 221 (1981), Kratochwil, N., et al.: Biochem. Pharmacol., 64, 1355 (2002), O'Brien, S., et al.: J. Med. Chem., 48, 1287 (2005), Castilho, M., et al.: Bioorg. Med. Chem., 14, 516 (2006),<br></p>Formula:C18H19Cl2NO4Color and Shape:NeatMolecular weight:384.25Iso Fluconazole
CAS:Controlled Product<p>Impurity Fluconazole EP Impurity A<br>Applications Iso Fluconazole (Fluconazole EP Impurity A) is an impurity of Fluconazole (F421000). Fluconazole USP impurity A.<br>References Rogers, T., et al.: Antimicrob. Agents Chemother., 30, 418 (1986), Itoh, H., et al.: Chem. Pharmaceut. Bull., 48, 1148 (2000),<br></p>Formula:C13H12F2N6OColor and Shape:Off-WhiteMolecular weight:306.271H-1-Ethyl-d5 Candesartan
CAS:Controlled Product<p>Applications Labelled Candesartan (C175575) impurity.<br></p>Formula:C26H19D5N6O3Color and Shape:Off-White To Light YellowMolecular weight:473.54N’-[2-[2,4-(Dimethylphenyl)thio]phenyl] Vortioxetine
Controlled Product<p>Applications N’-[2-[2,4-Dimethylphenyl)thio]phenyl] Vortioxetine is an impurity of Vortioxetine (V766000, HBr salt) which is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT.<br>References Bang-Andersen, B., et al.: J. Med. Chem., 54, 3206 (2011); Mørk, A., et al.: J. Pharmacol. Exp. Ther., 340, 666 (2012); Mørk, A., et al.: Pharmacol. Biochem. Behav. 105C, 41 (2013)<br></p>Formula:C32H34N2S2Color and Shape:NeatMolecular weight:510.762-Chloromethyl-4-methoxy-3-methylpyridine Hydrochloride
CAS:Controlled Product<p>Applications A pyridine derivative used in the preparation of anti-ulcerative agents and other pharmaceutical compounds.<br>References Kuehler, T.C. et al.: J. Med. Chem., 38, 4906 (1995);<br></p>Formula:C8H10ClNO·ClHColor and Shape:NeatMolecular weight:208.085’-Oxo Amisulpride
CAS:Controlled Product<p>Applications 5’-Oxo Amisulpride is an impurity of the dopamine receptor antagonist Amisulpride (A633250).<br></p>Formula:C17H25N3O5SColor and Shape:Off-WhiteMolecular weight:383.462-(1-aminocyclohexyl)acetic acid
CAS:Controlled ProductFormula:C8H15NO2Color and Shape:NeatMolecular weight:157.213-Aminobenzotrifluoride
CAS:Controlled Product<p>Applications 3-Aminobenzotrifluoride is a known human toxin that can cause bacterial mutation and hepatocyte unscheduled DNA synthesis.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Reinhold, D., et al.: T. ASAE, 49, 2077 (2006); Thompson, C., et al.: Environ. Mutagen., 5, 803 (1983)<br></p>Formula:C7H6F3NColor and Shape:YellowMolecular weight:161.12N,N'-bis(2,6-Dimethylphenyl)-1,4-piperazinediacetamide
CAS:Controlled Product<p>Impurity Ranolazine USP Related Compound D<br>Applications N,N'-bis(2,6-Dimethylphenyl)-1,4-piperazinediacetamide is an intermediate of Ranolazine (R122500), an anti-ischemic agent which modulates myocardial metabolism. Ranolazine is also known to exert antianginal activities.<br>References Sampath, A., et al.: Org. Proc. Rsch. Dev., 16, 748 (2012); Chaitman, B.R., et al.: J. Am. Coll. Cardial., 43, 1375 (2004); McCormack, J.G., et al.: Gen. Pharmacol., 30, 639 (1998); Schofield, J.A.H., et al.: Expert Opin. Invest. Drugs, 11, 117 (2002)<br></p>Formula:C24H32N4O2Color and Shape:NeatMolecular weight:408.54(S)-Propyl Pramipexole
CAS:Controlled Product<p>Applications (S)- Propyl Pramipexole is (S)-Pramipexole (P700750) analogue. (S)-Pramipexole (P700750) is a dopamine-D2-receptor agonist. Antiparkinsonian. Pramipexole (Mirapex, Mirapexin, Sifrol) is a non-ergoline dopamine agonist indicated for treating early-stage Parkinson's disease (PD) and restless legs syndrome (RLS).[1] It is also sometimes used off-label as a treatment for cluster headache and to counteract the problems with sexual dysfunction experienced by some users of the selective serotonin reuptake inhibitor (SSRI) antidepressants.<br>References Mierau, J., et al.: J. Med. Chem., 30, 494 (1987);Schilling, J.C., et al.: Clin. Pharmacol. Ther., 51, 541 (1992);Kieburtz, K., et al.: J. Am. Med. Assoc., 278, 125 (1997);<br></p>Formula:C13H23N3SColor and Shape:NeatMolecular weight:253.41N-Des(4-Fluorophenyl)-N-(3-chlorophenyl)-ezetimibe
CAS:Controlled ProductFormula:C24H21ClFNO3Color and Shape:NeatMolecular weight:425.881-Nitroso-1-(2-Hydroxyethyl)-3-(2-chloroethyl)urea
CAS:Controlled ProductFormula:C5H10ClN3O3Color and Shape:Off-WhiteMolecular weight:195.6Lomustine
CAS:Controlled Product<p>Applications Chloroethylnitrosourea derivative with antitumor activity. Similar to carmustine, chlorozotocin, nimustine, ranimustine. Antineoplastic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Johnston, T.P., et al.: J. Med. Chem., 9, 892 (1966), Oliverio, V.T., et al.: Cancer Res., 30, 1330 (1970), Thompson, G.R., et al.: Toxicol. Appl. Pharmacol., 21, 405 (1972), Al-Shammary, F.J., et al.: Anal. Profiles Drug Subs., 19, 315 (1990),<br></p>Formula:C9H16ClN3O2Color and Shape:NeatMolecular weight:233.702-(Trifluoroacetyl)-4-chloroaniline, Hydrochloride Hydrate
CAS:Controlled Product<p>Applications HIV reverse transcriptase inhibitor.<br></p>Formula:C8H5ClF3NO·ClHColor and Shape:NeatMolecular weight:260.045-Methoxy-1-[4-(difluoromethyl)phenyl]-1-pentanone Oxime
CAS:Controlled Product<p>Applications Defluoro Fluvoxamine intermediate.<br></p>Formula:C13H17F2NO2Color and Shape:NeatMolecular weight:257.28N-(4-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine
CAS:Controlled Product<p>Applications Intermediate in the preparation of Imatinib impurities. It is a COVID19-related research product.<br></p>Formula:C16H15N5Color and Shape:NeatMolecular weight:277.32m-Salicylic Acid
CAS:Controlled Product<p>Applications m-Salicylic Acid is widely used in organic synthesis. It is also an important active metabolite of aspirin (A187780).<br>References Haynes, M., et al.: CRC H.b Chem. Phys., 92, 306 (2011)<br></p>Formula:C7H6O3Color and Shape:Off-WhiteMolecular weight:138.123-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one (Risperidone Impurity)
CAS:Controlled ProductFormula:C23H27FN4O2Color and Shape:NeatMolecular weight:410.48N-Desethyl N-Methyl Rivastigmine
CAS:Controlled Product<p>Impurity Rivastigmine EP Impurity B<br>Applications N-Desethyl N-Methyl Rivastigmine (Rivastigmine EP Impurity B) is an impurity of Rivastigmine (R541000), a brain selective acetylcholinesterase inhibitor. Nootropic.<br>References Rosler, M., et al.: Brit. Med. J., 318, 633 (1999), Enz, A., et al.: Prog. Brain Res., 98, 431 (1993),<br></p>Formula:C13H20N2O2Color and Shape:NeatMolecular weight:236.32Paliperidone N-Oxide
CAS:Controlled Product<p>Impurity Paliperidone USP Related Compound D<br>Applications One of the major degradation product of Risperidone in bulk drug and pharmaceutical dosage forms. Paliperidone USP Related Compound D.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Leysen, J., et al.: J. Pharmacol. Exp. Ther., 247, 661 (1988), Huang, M., et al.: Pharm. Drug Dispos., 54, 257 (1993), Smyth, W., et al.: Anal. Bioanal. Chem., 378, 1305 (2004),<br></p>Formula:C23H27FN4O4Color and Shape:NeatMolecular weight:442.48Ibrutinib Dimer (~90%)
CAS:<p>Applications Ibrutinib Dimer is a dimer impurity of Ibrutinib (I124970), a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor.<br>References MacGlashan, D., et. al.: Int. Immunol., 11, 475 (2011)<br></p>Formula:C50H48N12O4Purity:~90%Color and Shape:NeatMolecular weight:880.99Ezetimibe Hydroxy β-D-Glucuronide
CAS:Controlled Product<p>Applications A metabolite of Ezetimibe. Antilipemic.<br>References Shah, V., et al.: J. Pharm. Sci., 17, 1551 (2000), Van Heek, M., et al.: Br. J. Pharmacol., 134, 409 (2001), Patrick, J., et al.: Drug Metab. Dispos., 30, 430 (2002),<br></p>Formula:C30H29F2NO9Color and Shape:NeatMolecular weight:585.554-Fluoro-2-(hydroxymethyl)phenol
CAS:Controlled Product<p>Applications 4-Fluoro-2-(hydroxymethyl)phenol can be used in preparation of naphthyridine derivatives as chemokine receptor antagonists useful in the treatment of pain.<br>References Wang, X., et al.: PCT Int. Appl., WO 2013010453 A1 20130124 (2013)<br></p>Formula:C7H7FO2Color and Shape:NeatMolecular weight:142.1283,3-Diphenyl-oxiranecarboxylic Acid Methyl Ester
CAS:<p>Applications Ambrisentan intermediate.<br>References Amberg, W., et al.: J. Med. Chem., 42, 3026 (1999),<br></p>Formula:C16H14O3Color and Shape:NeatMolecular weight:254.28Brivaracetam-d7 (Mixture of Diastereomers)
Controlled Product<p>Applications Brivaracetam-d7 (Mixture of Diastereomers), is a mixture of 2 diastereomers of Brivaracetam-d7 (B677647), and a labeled analogue of Brivaracetam (B677645), 4-n-propyl analog of levetiracetam (L331500), and a racetam derivative with anticonvulsant properties.<br>References Rosenstiel, P., et al.:Neurotherapeutics, 4 (1), 84 (2007); Malawska, B., et al.:, Curr. Opin. Investig. Drugs, 6(7), 740 (2005);<br></p>Formula:C11H13D7N2O2Color and Shape:NeatMolecular weight:219.33Ethyl 2-Methoxy-5-sulfamoylbenzoate
CAS:Controlled Product<p>Impurity Sulpiride EPimpurity C<br>Applications ethyl 2-methoxy-5-sulfamoylbenzoate (cas# 33045-53-3) is a useful research chemical.<br></p>Formula:C10H13NO5SColor and Shape:NeatMolecular weight:259.28Deschloro-4’-chloro Clomiphene Hydrochloride
CAS:Controlled Product<p>Applications An impurity of Clomiphene (C587025).<br></p>Formula:C26H29Cl2NOColor and Shape:NeatMolecular weight:442.42N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers)
CAS:Controlled Product<p>Applications N-(1-Carboxy-3-phenylpropyl)-S-lisinopril (Mixture of diastereomers) is an impurity of lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor.<br>References Shinde, V., et. al.: J. Pharm. Biomed. Anal., 43, 381 (2007); Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)<br></p>Formula:C31H41N3O7Color and Shape:NeatMolecular weight:567.67N-[3-Methyl-1-(1-phenylcyclobutyl)butyl]-N,N-dimethylamine Hydrochloride
CAS:Controlled Product<p>Applications N-[3-Methyl-1-(phenylcyclobutyl)butyl]-N,N-dimethylamine Hydrochloride is an impurity of Sibutramine Hydrochloride (S422500), a serotonin and noradrenaline reuptake inhibitor.<br>References Hanotin, C., et al.: Int. J. Obesity, 22, 32 (1998)<br></p>Formula:C17H27N·ClHColor and Shape:NeatMolecular weight:281.86N-Desmethyl-4-hydroxy Tamoxifen β-D-Glucuronide (E/Z Mixture)
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications A novel active metabolite of the anti-cancer drug Tamoxifen (T006000).<br>References Furr, B., et al.: Pharmacol. Ther., 25, 127 (1984), Leonessa, F., et al.: Cancer Res., 54, 441 (1994), Stearns, V., et al.: Lancet, 360, 1851 (2002), Rae, J., et al.: Pharmacogenetics, 13, 501 (2003), Zheng, Y., et al.: Drug Metab. Dispos., 35, 1942 (2007),<br></p>Formula:C31H35NO8Color and Shape:NeatMolecular weight:549.61(S)-Carisbamate
CAS:<p>Applications Carisbamate is being developed for adjuvant treatment of partial onset epilepsy. Carisbamate produces anticonvulsant effects in primary generalized, complex partial and absence-type seizure models, and exhibits neuroprotective and antiepileptogenic properties in rodent epilepsy models.<br>References Novak GP, et al. 2007. Neurotherapeutics. Jan;4(1):106-9Nau C, 2004. J Membr Biol. Sep 1;201(1):1-8Codd EE, 2008. Pain. Feb;134(3):254-62. Epub 2007 May 25<br></p>Formula:C9H10ClNO3Color and Shape:NeatMolecular weight:215.632-Nitrodeamino Fingolimod
CAS:Controlled Product<p>Applications An impurity of Fingolimod (F805000, HCl salt), a novel immune modulator that prolongs allograft transplant survival in numberour models by inhibiting lymphocyte emigration from lymphoid organs.<br>References Brinkmann, V., et al.: Transplantation, 72, 764 (2001), Brinkmann, et al.: J. Biol. Chem., 277, 24, 21453 (2002), Mtaloubian, M., et al.: Nature, 427, 355 (2004),<br></p>Formula:C19H31NO4Color and Shape:NeatMolecular weight:337.453-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine
CAS:Controlled Product<p>Stability Air Sensitive<br>Applications 3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine is used in the preparation of c-Src and Abl inhibitors based on the scaffold present in Imatinib (G407000), used in the treatment of myelogenic leukemia. It is a COVID19-related research product.<br>References Seeliger, M. et al.: Canc. Res., 69, 2384 (2009); Schindler, T., et al.: Science, 289, 1938 (2000); Drucker, B.J., et al.: N. Engl. J. Med., 344, 1031 (2001)<br></p>Formula:C11H10N3F3Color and Shape:NeatMolecular weight:241.21Haloperidol Decanoate
CAS:Controlled Product<p>Applications Antidyskinetic; antipsychotic.<br>References Janicki, C.A., et al.: Anal. Profiles Drug Subs., 9, 341 (1980), Beresford, R., et al.: Drugs, 33, 31 (1987)<br></p>Formula:C31H41ClFNO3Color and Shape:NeatMolecular weight:530.114-Hydroxy-2-methyl- 1,1-dioxide-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide
CAS:Controlled ProductFormula:C8H8N2O4S2Color and Shape:NeatMolecular weight:260.293-Chlorobenzyl Cyanide
CAS:Controlled Product<p>Applications 3-Chlorobenzyl Cyanide is a useful synthetic intermediate. It was used to design EGFR Tyrosine Kinase Inhibitors. It can also be used to synthesize imidoyl thioureas as non-nucleoside reverse transcriptase inhibitors.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Traxler, P., et al.: J. Med. Chem., 42, 1018 (1999); Ludovici, D., et al.: Bioorg. Med. Chem. Lett., 11, 2225 (2001)<br></p>Formula:C8H6ClNColor and Shape:NeatMolecular weight:151.59Thiorphan Disulfide
CAS:Controlled Product<p>Applications Thiorphan Disulfide is an impurity of Racecadotril (R070600); an antidiarrheal and enkephalinase inhibitor that reduces the amount of water and electrolytes into the intestine.<br>References Cezard, J., et al.: Gastroenterol., 120, 799 (2001); Sato, T., et al.: J. Med. Chem., 51, 7705 (2008); Lakshmana, P., et al.: J. Pharm. Res., 8, 39 (2009); Fournie-Zaluski<br></p>Formula:C24H28N2O6S2Color and Shape:NeatMolecular weight:504.623-Bromo-2-methylpropionic Acid
CAS:<p>Impurity Captopril EP Impurity D<br>Stability Hygroscopic<br>Applications 3-Bromo-2-methylpropionic Acid (Captopril EP Impurity D) is used in the preparation of captopril selenium analogs as antioxidants and ACE inhibitors used as antihypertensive drugs.<br>References Bhuyan, B. et al.: Org. Biomol. Chem., 9, 1356 (2011);<br></p>Formula:C4H7BrO2Color and Shape:Colourless LiquidMolecular weight:167.00Benzo[b]thien-2-yl Ketone (Zileuton Impurity)
CAS:Controlled Product<p>Applications Benzo[b]thien-2-yl ketone is an impurity of Zileuton (Z420000), an inhibitor of 5-lipoxygenase that is used to treat patients with asthma. Benzo[b]thien-2-yl ketone is used as a reagent to synthesize Bis(1H-2-indolyl)methanone, compounds that inhibit the activity of growth factor receptor kinase. Benzo[b]thien-2-yl ketone is also used as a reagent to prepare annulated oligothiophenes, compounds that are used in organic light-emitting devides (OLEDs).<br>References Israel, E., et al.: JAMA, 275, 931 (1996); Mahboobi, S., et al.: J. Med. Chem., 45, 1002 (2002); Mitschke, U. & Bäuerle, P.: J. Chem. Soc. Perk. Trans., 1, 740 (2001); Nenajdenko, V., et al.: Russ. Chem. Bull., 61, 1456 (2012)<br></p>Formula:C17H10OS2Color and Shape:NeatMolecular weight:294.394-Hydroxy Ramelteon
CAS:<p>Applications A metabolite of Ramelteon (R110051)<br></p>Formula:C16H21NO3Color and Shape:Off White SolidMolecular weight:275.34Loratadine-d5
CAS:Controlled Product<p>Applications Loratadine-d5 is the labeled analogue of Loratadine (L469575), a nonsedating-type histamine H1-receptor.<br>References Bruttmann, G., et al.: J. Allergy Clin. Immunol., 83, 411 (1989); Haria, M., et al.: Drugs, 48, 617 (1994)<br></p>Formula:C22H18D5ClN2O2Color and Shape:NeatMolecular weight:387.913-Amino-2-chloro-propenal
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 3-Amino-2-chloro-propenal is a chemical reagent in the synthesis of a COX-2 specific inhibitor.<br>References Davies, I. et al.: J. Org. Chem., 65, 8415 (2000);<br></p>Formula:C3H4ClNOColor and Shape:NeatMolecular weight:105.521-Adamantan-d15-amine
CAS:Controlled Product<p>Applications 1-Adamantan-d15-amine is a labeled NMDA-receptor antagonist. Antiviral; antiparkinsonian.<br>References Vernier, V.G., et al; Toxicol. Appl. Pharmacol., 15, 642 (1969); Kirschbaum, J., et al.: Anal. Profiles Drug Subs., 12, 1 (1983)<br></p>Formula:C102H15H2NColor and Shape:White To BeigeMolecular weight:166.34DL-threo-Droxidopa-d3 Hydrochloride Salt Hydrate
CAS:Controlled Product<p>Applications DL-threo-Droxidopa-d3 Hydrochloride Salt Hydrate is an isotope labeled compound of DL-threo-Droxidopa (D689950), a synthetic amino acid precursor of Norepinephrine. An Antiparkinson.<br>References Bartholini, J., et al.: J. Pharmacol. Exp. Ther ., 193, 523 (1975), Kato, T., et al.: Biochem. Pharmacol., 36, 3051 (1987), Kawabata, A., et al.: Br J. Pharmacol., 111, 503 (1994)<br></p>Formula:C9H8D3NO5•HCl•x(H2O)Color and Shape:NeatMolecular weight:216.2136461802(Z)-4-(2,4-Difluorobenzoyl)piperidine Oxime
CAS:Controlled Product<p>Applications Intermediate in the preparation of Risperidone (R525000) and it’s derivatives.<br></p>Formula:C12H14F2N2OColor and Shape:NeatMolecular weight:240.24927-Hydroxyquinoline-(1H)-2-one
CAS:Controlled ProductFormula:C9H7NO2Color and Shape:NeatMolecular weight:161.16N10-Monodesmethyl Rizatriptan
CAS:Controlled Product<p>Impurity Rizatriptan EP Impurity I<br>Applications N10-Monodesmethyl Rizatriptan (Rizatriptan EP Impurity I) is a metabolite of Rizatriptan.<br>References Dechant, K., et al.: Drugs, 43, 776 (1992), Castro, J., et al.: Bioorg. Med. Chem. Lett., 3, 993 (1993), Lee, Y., et al.: Biopharm. Drug Dispos., 19, 577 (1998), Chen, J., et al.: J. Pharm. Biomed. Anal., 35, 639 (2004),<br></p>Formula:C14H17N5Color and Shape:NeatMolecular weight:255.324-(Diphenylmethyl)-1-nitrosopiperidine
CAS:Controlled ProductFormula:C18H20N2OColor and Shape:NeatMolecular weight:280.37Cabergoline
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Cabergoline is an ergot derivative and a dopamine D2-receptor agonist (1,2,3). It inhibits the secretion of prolactin and growth hormone.<br>References (1) Kvernmo, T., et al.: Clin.Ther. 28 1065 (2006)(2) Boutinaud, M., et al.: J Dairy Sci. 99, 5707 (2016)(3) Hutton, J.T., et al.: Neurology, 46, 1062 (1996<br></p>Formula:C26H37N5O2Color and Shape:White To Off-WhiteMolecular weight:451.60Cibenzoline
CAS:Controlled Product<p>Applications Cibenzoline acts as a highly active class I antiarrhythmic agent.<br>References Xie, C. et al.: Handbook. Metab. Pathway. Xenobio., 3, 1110 (2014);<br></p>Formula:C18H18N2Color and Shape:NeatMolecular weight:262.354,5-Dichlorothiophene-2-carboxylic Acid
CAS:Controlled Product<p>Applications 4,5-Dichlorothiophene-2-carboxylic Acid is used in the preparation of compounds that have therapeutic BACE1 and BACE2 inhibitors which are used for the treatment of Alzheimer’s disease, type 2 diabetes and other metabolic disorders.<br>References Banner, D., et al.: PCT Int. Appl., 2011:1438553 (2013)<br></p>Formula:C5H2Cl2O2SColor and Shape:NeatMolecular weight:197.04N-Ethyl-N-nitroso-2-propanamine (100 μg/mL in Methanol)
CAS:Controlled ProductFormula:C5H12N2OColor and Shape:ColourlessMolecular weight:116.16165-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Ethyl Ester
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Bendamustine (B132500) impurity.<br></p>Formula:C18H26ClN3O3Color and Shape:NeatMolecular weight:367.872-(1-Amino-1-methylethyl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide
CAS:Controlled Product<p>Applications An intermediate in the preparation of HIV-integrase inhibitors<br>References Summa, V., et al.: J. Med. Chem., 51, 5843 (2008),<br></p>Formula:C16H19FN4O3Color and Shape:NeatMolecular weight:334.35R-Amisulpride
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications R-Amisulpride is an isomer of the antipsychotic Amisulpride (A633250). R-Amisulprideis a potential antidiabetic agent.<br>References Roix, J.J., et. al.: Diabetes Obesity Metab., 14, 329 (2012)<br></p>Formula:C17H27N3O4SColor and Shape:NeatMolecular weight:369.484-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol Hydrochloride (Duloxetine Impurity)
CAS:Controlled Product<p>Impurity D721000<br>Applications Duloxetine impurity; also a related compound of Duloxetine metabolite.<br></p>Formula:C18H19NOS·ClHColor and Shape:NeatMolecular weight:333.88Dipyridamole Mono-O-b-D-glucuronide
CAS:Controlled Product<p>Applications A metabolite of Dipyridamole.<br>References Zak, S.B., et al.: J. Pharmacol. Exp. Ther., 141, 392 (1963),<br></p>Formula:C30H48N8O10Color and Shape:NeatMolecular weight:680.75Ebastine N-Oxide
CAS:<p>Stability -20°C Freezer<br>Applications Ebastine N-Oxide is an impurity of Ebastine (E320000). Ebastine impurity F and G (mixture of cis/trans).<br>References Yardley, J., et al.: J. Med. Chem., 33, 2899 (1990), Johnson, R., et al.: J. Antibiot., 49, 788 (1996), Takekawa, K., et al.: Xenobiotica, 31, 11 (2001), Chen, Z., et al.: Bioorg. Med. Chem. Lett., 14, 5275 (2004),<br></p>Formula:C32H39NO3Color and Shape:NeatMolecular weight:485.66Chlorpromazine-d6 Hydrochloride
CAS:Controlled Product<p>Applications Labelled Chlorpromazine (C424750). Used as an antiemetic; antipsychotic.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Anden, N.-E., et al.: Eur. J. Pharmacol., 11, 303 (1970), Curzon, G., et al.: Trends Pharmacol. Sci., 11, 61 (1990),<br></p>Formula:C172H6H13ClN2S·ClHColor and Shape:White To Light YellowMolecular weight:361.36Montelukast Cyclized Ether impurity
CAS:Controlled Product<p>Applications A cyclic ether impurity of antiasthmatic Montelukast (M568000).<br>References Egekeze, J.O. et al.: Anal. Chem., 67, 2292 (1995);<br></p>Formula:C29H26ClNOColor and Shape:NeatMolecular weight:439.98N-Nitroso-(1S,2R)-ephedrine
CAS:Controlled ProductFormula:C10H14N2O2Color and Shape:NeatMolecular weight:194.23N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N-methylnitrous amide
CAS:Controlled ProductFormula:C12H14N4O2Color and Shape:NeatMolecular weight:246.2710-Acetyloxy Oxcarbazepine
CAS:Controlled Product<p>Applications An intermediate in the preparation of Carbamazepine metabolites.<br>References Heckendorn, R., et al.: Helv. Chimica Acta, 70, 1955 (1987),<br></p>Formula:C17H14N2O4Color and Shape:NeatMolecular weight:310.301-Methyl-1H-indazole-3-carboxylic Acid Anhydride
CAS:Controlled Product<p>Applications 1-Methyl-1H-indazole-3-carboxylic Acid Anhydride is an impurity of Granisetron (G780000), a specific serotonin (5HT3) receptor antagonist and a antiemetic agent.<br>References Kilpatrick, G.J., et al.: Nature, 330, 746 (1987); Durig, T., et al.: J. Pharm. Sci., 86, 1092 (1997); Yuasa, H., et al.: Chem. Pharm. Bull., 44, 1361 (1996); Vishnu, E.V.R., et al.: Lett. Org. Chem., 8, 722 (2011);<br></p>Formula:C18H14N4O3Color and Shape:Off-WhiteMolecular weight:334.33α-(2,4-Difluorophenyl)-1H-1,2,4-triazole-1-ethanol
CAS:Controlled ProductFormula:C10H9F2N3OColor and Shape:NeatMolecular weight:225.19Dacomitinib
CAS:Controlled Product<p>Applications Dacomitinib is an Erb-inhibitor, or an inhibitor of the members of the epidermal growth factor receptor family. Used as an ant-cancer agent due to observation of over-expressed epidermal growth factor receptor in nearly all cases of squamous cell carcinoma in the head and neck.<br>References Williams, J. et al.: PLoS., 9, e98557 (2014); Peters, S. et al.: Canc. Treatment Rev., 40, 917 (2014);<br></p>Formula:C24H25ClFN5O2Color and Shape:NeatMolecular weight:469.944-(Methylamino)-3-nitrobenzoic Acid
CAS:Controlled Product<p>Applications 4-(Methylamino)-3-nitrobenzoic Acid (cas# 41263-74-5) is a compound useful in organic synthesis.<br></p>Formula:C8H8N2O4Color and Shape:NeatMolecular weight:196.16Elvitegravir-d6 (Major)
CAS:Controlled Product<p>Applications A novel labelled inhibitor of human immunodeficiency virus type 1 integrase.<br>References Chou, T., et al.: Eur. J. Biochem., 115, 207 (1981), Baba, M., et al.: Antimicrob. Agents Chemother., 31, 1613 (1987), Craigie, R., et al.: J. Biol. Chem., 276, 23213 (2001), Chen, X., et al.: J. Mol. Biol., 380, 504 (2008),<br></p>Formula:C23H17D6ClFNO5Color and Shape:NeatMolecular weight:453.913-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin
CAS:Controlled Product<p>Applications 3-Amino-4-(2,4,5-trifluorophenyl)butanyl Sitagliptin is an impurity of Sitagliptin (S490990). Sitagliptin is a trizolopyrazine dipeptidyl peptidase IV inhibitor. It has recently been approved for the therapy of type II diabetes.<br>References Kim, D., et al.: J. Med. Chem., 48, 141 (2005), Ahren, B., et al.: Eur. J. Pharmacol., 521 164 (2005), Bergman, A., et al: Clin. Ther., 28, 55 (2006)<br></p>Formula:C26H23F9N6O2Color and Shape:NeatMolecular weight:622.48542-Acetylbenzothiophene
CAS:Controlled Product<p>Applications A novel anti-osteoporosis agent, by enhansing expression of the BMP-2 gene.<br>References Horiguchi, Y., et al.: Chem. Pharm. Bull., 52, 214 (2004), Joshi, E., et al.: Chem. Res. Toxicol., 17, 137 (2004), Liu, Z., et al.: Bioorg. Med. Chem. Lett., 19, 4167 (2009),<br></p>Formula:C10H8OSColor and Shape:NeatMolecular weight:176.233-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] Balsalazide Sodium Salt (>90%)
CAS:Controlled Product<p>Applications An impurity of the anti-inflammatory drug Balsalazide (B116300).<br></p>Formula:C27H24N6O9xNaPurity:>90%Color and Shape:NeatMolecular weight:576.51(free acid)3,4-Dichloro Trazodone Dihydrochloride
CAS:Controlled Product<p>Applications 3,4-Dichloro Trazodone is the dichlorinated analogue and impurity of the antidepressant agent Trazodone (T718500).<br>References Pai, N.R. et al.: J. Chem. Pharmac. Res., 2, 458 (2010); Pai, N. et al.: Int. J. Pharmac. Sci. Rev. Res., 4, 180 (2010);<br></p>Formula:C19H21Cl2N5O•2HCiColor and Shape:NeatMolecular weight:406.3123646L-Valinol
CAS:Controlled Product<p>Applications L-Valinol is used as a reagent in the synthesis of simple 1,3-thiazolidine-2-thione derivatives which can exhibit fungicidal activity. L-Valinol is also used as a reagent in the synthesis of small-molecule inhibitors of MDM2-p53 protein-protein interaction (MDM2 inhibitors) in clinical trials for the treatment of cancer.<br>References Chen, N., et al.: Phosphorus Sulfur, 190, 112 (2015); Zhao, Y., et al.: J. Med. Chem., 58, 1038 (2015)<br></p>Formula:C5H13NOColor and Shape:WhiteMolecular weight:103.163Efavirenz Amino Alcohol Ethyl Carbamate
CAS:Controlled Product<p>Applications Efavirenz Amino Alcohol Ethyl Carbamate is used in the synthesis of Efavirenz (E425000), a potent non-nucleoside HIV-1 reverse transcriptase inhibitor. Antiviral<br>References Young, S.D., et al.: Antimicrob. Ag. Chemother., 39, 2602 (1995)<br></p>Formula:C16H15ClF3NO3Color and Shape:NeatMolecular weight:361.746a-Naloxol
CAS:Controlled Product<p>Applications 6α-Naloxol is a metabolite of Naloxone (N285000), a specific opioid antagonist. Narcotic antagonist.<br>References Chatterjie, N., et al.: J. Med. Chem., 18, 490 (1975); Bilsky, E., et al.: J. Pharmacol. Exp. Ther., 277, 484 (1996); Blokhina, E., et al.: Eur. J, Pharmacol., 406, 227 (2000); Jasinski, D.R., et al.: J. Pharmacol. Exp. Ther., 157, 420 (1967); McNicholas, L.F., et al.: Drugs, 27, 81 (1984); Hasson, M.M.A., et al.: Anal. Profiles Drug Subs., 14, 453 (1985); Stowe, C., et al.: Ann. Pharmacother., 27, 447 (1993)<br></p>Formula:C19H23NO4Color and Shape:NeatMolecular weight:329.39Ibudilast
CAS:Controlled Product<p>Applications A leukotriene D4 antagonist. Used as an antiallergic, antiasthmatic, and vasodilator (cerebral). PDE inhibitor (non-selective).<br>References Nishino, K., et al.: Japan J. Pharmacol., 33, 267 (1983), Ohashi, M., et al.: Arch. Int. Pharmacodyn., 280, 216 (1986), Armstead, W.M., et al.: J. Pharmacol., Exp. Ther., 244, 138 (1988),<br></p>Formula:C14H18N2OColor and Shape:NeatMolecular weight:230.31Desmethyl Cariprazine
CAS:<p>Applications Desmethyl Cariprazine, is a derivative of Cariprazine (C183490) which is an orally active D2/D3 dopamine receptor antagonist (1,2,3). Cariprazine is an antipsychotic drug candidate for the potential treatment of schizophrenia, bipolar mania and depression.<br>References Gruender, G.: Curr. Opin. Invest. Drugs, 11, 823 (2010); Seneca, N. et al.: Psychopharmacology, 218, 579 (2011); Kiss, B. et al.: J. Pharmacol. Exp. Therap., 333, 328 (2010)<br></p>Formula:C20H30Cl2N4OColor and Shape:NeatMolecular weight:413.38Perampanel-d5 (1.0mg/ml in Acetonitrile)
CAS:Controlled ProductFormula:C23D5H10N3OColor and Shape:ColourlessMolecular weight:354.42Fenspiride N-Oxide
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications Fenspiride N-Oxide is an impurity of Fenspiride (F265000),an bronchodilator with anti-inflammatory properties. Inhibits mucus secretion and reduces the release of tachykinins at a prejunctional level by its anti-muscarinic action.<br>References Arnone, A., et al.: Tetrahedron., 54, 7831 (1998);<br></p>Formula:C15H20N2O3Color and Shape:NeatMolecular weight:276.331-(2,4-Bis(benzyloxy)phenyl)ethanone
CAS:Controlled Product<p>Applications 1-(2,4-Bis(benzyloxy)phenyl)ethanone is a useful research chemical for organic synthesis and other chemical processes.<br>References Chen, D., et al.: Eur. J. Med. Chem., 87, 765 (2014); Malik, N., et al.: Tetrahedron Lett., 54, 4121 (2013)<br></p>Formula:C22H20O3Color and Shape:NeatMolecular weight:332.392-Amino Edoxaban Methanesulfonate
CAS:Controlled ProductFormula:C16H22ClN5O3•(CH4O3S)Color and Shape:NeatMolecular weight:463.93Anagrelide-13C3
CAS:Controlled ProductFormula:C713C3H7Cl2N3OColor and Shape:NeatMolecular weight:259.071H-1-Ethyl Candesartan
CAS:Controlled Product<p>Applications Candesartan (C175575) impurity.<br></p>Formula:C26H24N6O3Color and Shape:WhiteMolecular weight:468.512-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol
CAS:Controlled Product<p>Applications 2-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]ethanol is used as a reagent in the synthesis of Ticagrelor (T437700) derivatives as antiplatelet agents.<br>References Zhang, H., et al.: Bioorg. Med. Chem. Lett., 22, 3598 (2012)<br></p>Formula:C17H27ClN4O4SColor and Shape:NeatMolecular weight:418.94Gabapentin Ethyl Ester Hydrochloride
CAS:Controlled Product<p>Applications Protected Gabapentin (G117250). Amino acid structurally related to γ-Aminobutyric Acid (GABA), designed to cross the blood brain barrier. Used as an anticonvulsant.<br>References Vollmer, K.-O. et al.: Arzneimittel-Forshc., 36, 830 (1986), Saletu, B., et al.: Int. J. Clin. Pharmacol. Ther. Toxicol., 24, 362 (1986)<br></p>Formula:C11H21NO2·ClHColor and Shape:NeatMolecular weight:235.75Nilotinib 3-Imidazolyl N-oxide
CAS:Controlled Product<p>Applications 4-Methyl-3-(4-pyridin-3-yl)pyrimidin-2-yl]amino-N-(5-(3-oxo-4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamine is an impurity compound of Nilotinib (N465300), useful in the treatment of chronic myelogenous leukemia. It is a COVID19-related research product.<br>References Wei-Sheng H., et al.: Synthesis, 14, 2121 (2007); Corbin, A., et al.: J. Biol. Chem., 277, 32214(2002), Golemovic, M., et al.: Clin. Cancer Res., 11, 4941 (2005), Gleixner, K., et al.: Blood, 107, 752 (2006), Nicolini, F., et al.: Leukemia, 20, 1061 (2006),<br></p>Formula:C28H22F3N7O2Color and Shape:NeatMolecular weight:545.523-Methoxy Favipiravir
CAS:Controlled ProductFormula:C6H6FN3O2Color and Shape:NeatMolecular weight:171.136-Oxo-(S,S)-Palonosetron (~90%)
CAS:Controlled Product<p>Applications 6-Oxo-(S,S)-Palonosetron is an impurity of (S,S)-Palonosetron (P165800), a serotonin 5-HT3 receptor antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). Antiemetic.<br>References Clark, R.D., et al.: J. Med. Chem., 36, 2645 (1993), Wong, E.H.F., et al.: Br. J. Pharmacol., 114, 851 (1995), Grunberg, S.M., et al.: Expert. Opin. Pharmacother., 4, 2297 (2003), Eisenberg, P., et al.: Ann. Oncol., 15, 330 (2004), Siddiqui, M.A.A., et al.: Drugs, 64, 1125 (2004),<br></p>Formula:C19H22N2O2Purity:~90%Color and Shape:NeatMolecular weight:310.39Everolimus Retroaldol Degradation Product
CAS:Controlled Product<p>Impurity Everolimus Impurity<br>Stability Light and temperature Sensitive<br>Applications Everolimus Retroaldol Degradation Product is an impurity of Everolimus (E945400). Everolimus is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation. Everolimus Impurity D<br>References Dumont, F.J., et al.: Curr. Opin. Invest. Drugs, 2, 1220 (2001), Kovarik, J. M., et al.: Clin. Pharmacol. Ther., 69, 48 (2001), Nashan, B., et al.: Ther. Drug Monit., 24, 53 (2002),<br></p>Formula:C53H83NO14Color and Shape:NeatMolecular weight:958.22N-Despropyl Ropinirole-d3
CAS:Controlled Product<p>Applications An isotopically Labelled metabolite of Ropinirole.<br>References Coldwell, M., et al.: Br. J. Pharmacol., 127, 1135(1999), Ramji, J., et al.: Xenobiotica, 29, 311 (1999)<br></p>Formula:C13H15D3N2OColor and Shape:NeatMolecular weight:221.31Everolimus NHS-carbonate (>85%)
Controlled Product<p>Applications Everolimus NHS-carbonate is a derivative of Everolimus (E945400), a macrolide immunosuppressant.<br></p>Formula:C58H86N2O18Purity:>85%Color and Shape:NeatMolecular weight:1099.3064-Cyano Loratadine
CAS:Controlled Product<p>Applications Intermediate for the synthesis of 4-Hydroxymethyl Loratadine.<br>References Cerrada, V., et al.: ARKIVOC, 9, 200 (2005).<br></p>Formula:C23H22ClN3O2Color and Shape:NeatMolecular weight:407.89Desacetyl Diltiazem-d3
CAS:Controlled Product<p>Applications A labelled metabolite of Diltiazem (D460620).<br>References Shallcross, H., et al.: Br. Med. J., 295, 1236 (1987), Yeung, P.K.F., et al.: Drug Metab. Dispos., 18, 1055 (1990), Cashman, J.R., et al.: J. Med. Chem., 34,2049 (1991),<br></p>Formula:C20H21D3N2O3SColor and Shape:NeatMolecular weight:375.5Indomethacin 1-Glycerin Ester
CAS:<p>Applications Indometacin 1-Glycerin Ester was synthesized and evaluated for anti-flammatory activity in the rate paw carrageenin edema essay.<br>References Paris, Gerard. , et al.: J. Med. Chem, 23, 9 (1980)<br></p>Formula:C22H22ClNO6Color and Shape:NeatMolecular weight:431.87N-Nitro-1,2,3,4-tetradehydro Argatroban
CAS:Controlled Product<p>Applications N-Nitro-1,2,3,4-tetradehydro Argatroban is an intermediate in the preparation of Argatroban (A769000).<br></p>Formula:C23H31N7O7SColor and Shape:White To Off-WhiteMolecular weight:549.601,4,8,11-Tetraazacyclotetradecane
CAS:Controlled Product<p>Applications 1,4,8,11-Tetraazacyclotetradecane is macrocyclic ligand that is used as an antioxidant in rubber and has been shown to suppress oxidation catalyzed by some metal ions.<br>References Goh, S.H.: Poly, Degrad, Stab., 8, 123 (1984);<br></p>Formula:C10H24N4Color and Shape:NeatMolecular weight:200.32(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl
CAS:Controlled Product<p>Applications Tadalafil (T004500) derivative. Used in the preparation of pyrazinopyridoindole derivatives for their PDE5 inhibitory activity.<br>References Beghyn, T. et al.: Bioorgan. Med. Chem. Lett. 17, 789(2007)<br></p>Formula:C20H18N2O4Color and Shape:Off White SolidMolecular weight:350.37Ambroxol Cycloimine Impurity
CAS:Controlled Product<p>Applications 4-(6,8-Dibromo-3(4H)-quinazolinyl)-cyclohexanol is an impurity of Ambroxol (A575900), a bronchosecretolytic drug.<br>References Jauch, R., et al.: Arzneim-Forsch., 13, 474 (1963)<br></p>Formula:C14H16Br2N2OColor and Shape:NeatMolecular weight:388.09763’-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]propyl Domperidine (Domperidine Impurity F)
CAS:Controlled Product<p>Impurity Domperidone EP Impurity F<br>Applications An impurity of the gastrokinetic and antinauseant drug Domperidone (D531100(P)), which is a novel peripheral dopamine receptor antagonist that does not cross the blood-brain barrier; anti-emetic. Domperidone(Motilium) is a dopamine blocker and an antidopaminergic reagent.<br>References Baudry, M., et al.: Arch. Pharmacol., 308, 231 (1979), Ennis, C., et al.: J. Pharm. Pharmacol., 31, 14 (1979), Brogden, R.N., Drugs, 24, 360 (1982),<br></p>Formula:C37H42Cl2N8O3Color and Shape:NeatMolecular weight:717.692-Amino-3-hydroxypyridine
CAS:Controlled Product<p>Applications 2-Amino-3-hydroxypyridine (cas# 16867-03-1) is a compound useful in organic synthesis.<br></p>Formula:C5H6N2OColor and Shape:NeatMolecular weight:110.11(R)-1-Methyl-3-pyrrolidinol
CAS:Controlled Product<p>Applications (R)-1-Methyl-3-pyrrolidinol is a useful synthetic intermediate. It is used for asymmetric synthesis of constrained (-)-S-adenosyl-L-homocysteine (SAH) analogs as DNA methyltransferase inhibitors.<br>References Isakovic, L., et al.: Bioorg. Med. Chem. Lett., 19, 2742 (2009); Gobbini, M., et al.:J. Med. Chem., 51, 4601 (2008)<br></p>Formula:C5H11NOColor and Shape:NeatMolecular weight:101.152-Thiopheneacetic Acid
CAS:Controlled ProductFormula:C6H6O2SColor and Shape:NeatMolecular weight:142.181-Bromo-2-(bromomethyl)-4,5-dimethoxybenzene
CAS:Controlled Product<p>Applications 1-Bromo-2-(bromomethyl)-4,5-dimethoxybenzene is used in the synthesis of novel histone deacetylase 1 inhibitors (HDAC 1). Also used in the synthesis of antibacterial gemifloxacin derivatives.<br>References Sun, Q. et al.L: Bioorg. Med. Chem. Lett., 23, 3295 (2013); Feng, L. et al. Eur. J. Med. Chem., 55, 125 (2012);<br></p>Formula:C9H10Br2O2Color and Shape:NeatMolecular weight:309.98Clonidine
CAS:Controlled Product<p>Applications Clonidine is an α2-Adrenergic agonist. Antihypertensive; analgesic for neuropathic pain.<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Roach, A.G., et al.: J. Pharmacol. Exp. Ther., 227, 421 (1983); Glassman, A.H., et al.: Science, 226, 864 (1984); Abounassif, A.M., et al.: Anal. Profiles Drug Subs. Excip., 21, 109 (1992);<br></p>Formula:C9H9Cl2N3Color and Shape:NeatMolecular weight:230.092-(4-(Methylsulfonamido)phenyl)acetic Acid
CAS:Controlled Product<p>Applications 2-(4-(Methylsulfonamido)phenyl)acetic Acid acts as a reagent for resiniferatoxin analogs preparation as metabolically stable TRPV1 agonists and potential analgesics. Preparation and structure-activity relationships of 2,6-diaryl-4-(phenacylamino)pyrimidines as selective adenosine A2A antagonists.<br>References Choi, H., et al.: Bioorg. Med. Chem. , 17, 690 (2009); Moorjani, M., et al.: Bioorg. Med. Chem. Lett., 18, 1269 (2008)<br></p>Formula:C9H11NO4SColor and Shape:NeatMolecular weight:229.25[3-(9H-Carbazol-4-yloxy)-2-hydroxy]propyl Carvedilol
CAS:Controlled ProductFormula:C39H39N3O6Color and Shape:NeatMolecular weight:645.746-Amino-1-methyl-5-nitrosouracil
CAS:Controlled Product<p>Stability Light and temperature sensitive<br>Applications 6-Amino-1-methyl-5-nitrosouracil is known to exhibit anitmicrobial activity and form complexation with platinum (II).<br>References Gaballa, A.S., et al.: Molec. Biomolec. Spectro. 75A, 146 (2010);<br></p>Formula:C5H6N4O3Color and Shape:NeatMolecular weight:170.131-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Sodium Salt
CAS:<p>Applications 1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid is an impurity of Rabeprazole. It is also a degradation product formed in stressed tablets of Rabeprazole sodium.<br>References Kommanaboyina, B., et al.: Drug Dev. Ind. Pharm., 25, 857 (1999); Carswel, C., et al.: Drugs, 61, 2327 (2001); Garcia, C., et al.: J. Pharm. Biomed. Anal., 46, 88 (2008)<br></p>Formula:C14H10N3NaO3Color and Shape:NeatMolecular weight:291.24Triciribine
CAS:Controlled Product<p>Applications Triciribine is an antitumor tricyclic nucleoside. Triciribine acts as a potent, small-molecule inhibitor of AKT phosphorylation in subjects with solid tumors contining activated AKT. Triciribine is also a selective inhibitor of HIV-1 and HIV-2, including strains known to be resistant to AZT or TIBO.<br>References Garrett, C.R. et al.: Invest. New Drugs, 29, 1381 (2011); Ptak, R.G. et al.: AIDS Res. Human Retrovir., 14, 1315 (1998); Bennett, L.L. et al.: BIochem. Pharmacol., 27, 233 (1978);<br></p>Formula:C13H16N6O4Color and Shape:NeatMolecular weight:320.302,2'-Ethylenedianiline
CAS:Controlled Product<p>Applications 2,2'-Ethylenedianiline is used as a reagent to synthesize Oxcarbazepine (O869250), a broad-specturm, second-generation anticonvulsant drug that is used to treat partial and complex partial seizures in children and adults. 2,2'-Ethylenedianiline is also used as a reagent to prepare a series of triterpines (e.g. Lupeol [L474850]), compounds that have chemopreventative activity.<br>References Asmaa, M., et al.: Pac. J. Cancer Prevent., 15, 475 (2014); Kalis, M. & Huff, N.: Clin. Ther., 23, 680 (2001); Malke, S., et al.: Pharm. Sci., 69, 211 (2007); Schmidt, D. & Elger, C.: Epil. Beh., 5, 627 (2004)<br></p>Formula:C14H16N2Color and Shape:NeatMolecular weight:212.29(alphaR)-α-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine Hydrochloride Salt
CAS:Controlled ProductFormula:C22H22F3N·ClHColor and Shape:NeatMolecular weight:393.87Losartan Trityl Ether
CAS:<p>Impurity Losartan EP Impurity I<br>Applications Losartan Trityl Ether (Losartan EP Impurity I) is an impurity of Losartan.<br>References Duncia, J.V., et al.: J. Med. Chem., 33, 1312 (1990),<br></p>Formula:C41H37ClN6OColor and Shape:NeatMolecular weight:665.23Dehydroxydehydro Terfenadine
CAS:Controlled ProductFormula:C32H39NOColor and Shape:NeatMolecular weight:453.663-O-Methyl Tolcapone-d4
CAS:Controlled Product<p>Applications Isotope labelled 3-O-Methyl Tolcapone is a metabolite of the catechol-O-Methyl transferase inhibitor Tolcapone (T535250).<br> Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package<br>References Jorga, K. et al.: Br. J. Clin. Pharmacol., 48, 513 (1999); Funaki, T. et al.: J. Pharm. Pharmacol., 46, 571 (1994); Sun, J. et al.: J. Chrom. B Anal. Technol. Biomed. Life Sci., 877, 2557 (2009); Heizmann, P. et al.: J. Chrom. B Biomed. Sci. Appl., 730, 153 (1999);<br></p>Formula:C15H9D4NO5Color and Shape:NeatMolecular weight:291.29Iguratimod
CAS:Controlled Product<p>Applications Iguratimod acts as an anti-inflammatory agent, used primarily in the treatment of rheumatoid arthritis.<br>References Estellat, C. et al.: Arch. Int. Med., 172, 237 (2012); Du, F. et al.: Arth. Res. Ther., 10 (2008); Tanaka, K. et al.: Rheumatol. Rep., 1, 11 (2009);<br></p>Formula:C17H14N2O6SColor and Shape:NeatMolecular weight:374.37N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide
CAS:Controlled Product<p>Applications N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide is derived from Diethyl 2-Acetamidomalonate (D443130), which is a versatile building block used for the synthesis of various pharmaceutical and biologically active compounds. It is an intermediate for the preparation of Novobiocin (N888500) analogues as potential heat shock protein 90 inhibitors.<br>References Gunaherath, G. M., et al.: Bioorg. Med. Chem., 21, 5118 (2013);<br></p>Formula:C25H39NO5Color and Shape:NeatMolecular weight:433.583-Ethyl Haloperidol
CAS:Controlled ProductFormula:C23H27ClFNO2Color and Shape:NeatMolecular weight:403.92Resiquimod
CAS:<p>Applications Resiquimod is an imidazoquinoline derivative that acts as an immune response modifier. Resiquimod shows antitumor and antiviral activity and is used in the treatment of skin lesions such as herpes simplex virus. Resiquimod is a toll-like receptor 9 (TLR7) agonist.<br>References Wu, J.J. et al.: Antivir. Res., 64, 79 (2004); Fife, K.H. et al.: Antimicrob. Agents Chemother., 52, 477 (2008); Szeimies, R.M. et al.: Brit. J. Dermatol., 159, 205 (2008);<br></p>Formula:C17H22N4O2Color and Shape:White SolidMolecular weight:314.38Rotigotine Hydrochloride
CAS:<p>Applications It is a non-ergot dopamine agonist drug and is indicated for the treatment of Parkinson’s disease.<br>References Loschmann, P., et al.: Eur. J. Pharmacol., 166, 373 (1989), Edgar, D., et al.: J. Pharmacol. Exp. Ther., 283, 757 (1997), Ferreira, J., et al.: Lancet, 355, 1333 (2000), Arnulf, I., et al.: Neurology, 58, 1019 (2002), Wisor, J., et al.: Neuroscience, 132, 1027 (2005),<br></p>Formula:C19H25NOS·ClHColor and Shape:White To Off-WhiteMolecular weight:351.93Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate
CAS:Controlled Product<p>Applications Methyl 4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate is an intermediate used in the synthesis of 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide (M326838), which is an impurity of Nilotinib (N465300), a possible agent in the treatment of chronic myelogenous leukemia.<br>References Corbin, A., et al.: J. Biol. Chem., 277, 32214 (2002); Golemovic, M., et al.: Clin. Cancer Res., 11, 4941 (2005); Gleixner, K., et al.: Blood, 107, 752 (2006); Nicolini, F., et al.: Leukemia, 20, 1061 (2006)<br></p>Formula:C18H16N4O2Color and Shape:NeatMolecular weight:320.35N-Cyano-N’,N”-bis[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine
CAS:Controlled Product<p>Applications N-Cyano-N’,N”-bis[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine is an impurity of Cimetidine (C441650)<br>References Ellis, D. R., et al.: J. Chromatogr. A, 808, 269-275 (1998)<br></p>Formula:C16H24N8S2Color and Shape:NeatMolecular weight:392.542,2'-[[[4-(3-Oxo-4-morpholinyl)phenyl]imino]bis[(2R)-2-hydroxy-3,1-propanediyl]]bis[1H-isoindole-1,3(2H)-dione]
CAS:Controlled Product<p>Stability Hygroscopic<br>Applications 2,2'-[[[4-(3-Oxo-4-morpholinyl)phenyl]imino]bis[(2R)-2-hydroxy-3,1-propanediyl]]bis[1H-isoindole-1,3(2H)-dione] is an impurity of Rivaroxaban (R538000), a novel antithrombotic agent. A highly potent and selective, direct FXa inhibitor.<br>References Ansell, J., et al.: Drugs, 64, 1 (2004), Eriksson, B., et al.: J. Thromb. Haemost., 3, 103 (2005), Kubitza, D., et al.: Clin. Pharmacol. Ther., 78, 412 (2005),<br></p>Formula:C32H30N4O8Color and Shape:NeatMolecular weight:598.6Repirinast (>80%)
CAS:Controlled ProductFormula:C20H21NO5Purity:>80%Color and Shape:NeatMolecular weight:355.38Leflunomide 3-Isomer
CAS:Controlled Product<p>Impurity Leflunomide EP Impurity C/ Leflunomide BP Impurity C<br>Applications Leflunomide 3-Isomer (Leflunomide EP Impurity C) is a Leflunomide analogue, with potential antiinflammatory and anti-viral activity. Leflunomide (L322750) Impurity E.<br>References Bertolini, G., et al.: J. Med. Chem., 40, 2011 (1997), Huang, W., et al.: Chem. Pharm. Bull., 51, 313 (2003),<br></p>Formula:C12H9F3N2O2Color and Shape:White To Off-WhiteMolecular weight:270.21Desthiazolylmethyloxycarbonyl Ritonavir
CAS:Controlled ProductFormula:C32H45N5O3SPurity:>85%Color and Shape:NeatMolecular weight:579.80N-Methylthiophene-2-carboxamide
CAS:Controlled ProductFormula:C6H7NOSColor and Shape:NeatMolecular weight:141.19Ticagrelor TCG Sulfonate
<p>Applications Ticagrelor TCG Sulfonate is an impurity of Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).<br>References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007),<br></p>Formula:C23H28F2N6O7S2Color and Shape:NeatMolecular weight:602.635-Methyl-1,3-benzenediacetonitrile
CAS:<p>Impurity Anastrozole 1,3-Dicyanomethyl Impurity<br>Applications 5-Methyl-1,3-benzenediacetonitrile is an Anastrozole intermediate. Anastrozole 1,3-Dicyanomethyl Impurity. Anastrozole is an aromatase inhibitor and used as an antineoplastic.<br>References Plourde, P.V., et al.: Breast Cancer Res. Treat., 30, 103 (1994), Buzdar, A.U., et al.: Cancer, 79, 730 (1997)<br></p>Formula:C11H10N2Color and Shape:NeatMolecular weight:170.21(E)-Naftifine
CAS:<p>Applications (E)-Naftifine is an intermediate in synthesizing Naftifine N-Oxide (N213110), which is an impurity or metabolite of Naftifine Hydrochloride (N213100), an allylamine antifungal agent.<br>References Georgopoulos, A., et al.: Antimicrob. Ag. Chemother., 19, 386 (1981); Meingassner, J.C., et al.: J. Invest. Dermatol., 77, 444 (1981); Paltauf, F., et al.: Biochim Biophys. Acta, 712, 268 (1982); Aggarwal, D., et al.: J. Pharm. Pharmacol., 56, 1509 (2004)<br></p>Formula:C21H21NColor and Shape:NeatMolecular weight:287.40Telmisartan Amide
CAS:<p>Impurity Telmisartan EP Impurity F / Telmisartan Amide<br>Applications An amide impurity of Temisartan (D294250).<br>References Xu, G. et al.: Zhong. Yiyao Gong. Zaz., 40, 714 (2009);<br></p>Formula:C33H31N5OColor and Shape:NeatMolecular weight:513.631-(2,5-Dimethylphenyl)ethanol
CAS:Controlled Product<p>Applications 1-(2,5-Dimethylphenyl)ethanol can be used as a reagent in reactions or as a aroma compound<br>References Zhou, J., et al.: Yuanyi Xuebao., 37, 1621-1628 (2010)<br></p>Formula:C10H14OColor and Shape:NeatMolecular weight:150.22Lumateperone-d4
CAS:Controlled ProductFormula:C24D4H24FN3OColor and Shape:NeatMolecular weight:397.5224-Hydroxy Tolvaptan (Mixture of Diastereomers)
CAS:Controlled Product<p>Applications Diastereomeric mixture of 4-Hydroxy Tolvaptan is an impurity of Tolvaptan (T536650), a selective, competitive arginine vasopressin V2 receptor antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).<br>References Ohtani, T., et al.: Heterocycles, 69, 333 (2006);<br></p>Formula:C26H25ClN2O4Color and Shape:NeatMolecular weight:464.94N1-Methyl-N2-2-pyridinylethanediamide
CAS:Controlled ProductFormula:C8H9N3O2Color and Shape:NeatMolecular weight:179.184-Desfluoro-3-Fluoro Bicalutamide
CAS:Controlled Product<p>Impurity Bicalutamide USP Related Compound B/ Bicalutamide EP Impurity B<br>Applications 3-Fluorophenyl Bicalutamide (Bicalutamide USP Related Compound B) is a steroisomer of Bicalutamide (B382000), non-steroidal peripherally active anti-androgen. Used as an antiandrogen, antineoplastic (hormonal).<br>References Tucker, H., et al.: J. Med. Chem., 31, 954 (1988), Cockshott, I.D., et al.: Eur. Urol., 18, Suppl. 3, 10 (1990), Cockshott, I., et al.: Br. J. Clin. Pharm., 36, 339 (1993), McKillop, D., et al.: Xenobiotica, 25, 623 (1995),<br></p>Formula:C18H14F4N2O4SColor and Shape:NeatMolecular weight:430.37Varenicline Carbamoyl β-D-Glucuronide
CAS:Controlled Product<p>Applications A metabolite of Varenicline.<br>References Toide, K., et al.: Biochem. Pharmacol., 67, 1269 (2004), Coe, J., et al.: J. Med. Chem., 48, 3474 (2005), Doll, R., et al.: Br. J. Cancer, 92, 426 (2005), Obach, R., et al.: Drug Metab. Dispos., 33, 262 (2005),<br></p>Formula:C20H21N3O8Color and Shape:NeatMolecular weight:431.4N-Trityl Candesartan Ethyl Ester
CAS:Controlled Product<p>Applications Candesartan analog as angiotensin II antagonist.<br>References Bakshi, M., et al.: J. Pharm. Biomed. Anal., 28, 1011 (2002),<br></p>Formula:C45H38N6O3Color and Shape:NeatMolecular weight:710.825-(2-Fluorophenyl)-5-oxovaleric Acid
CAS:Controlled Product<p>Applications 5-(2-Fluorophenyl)-5-oxovaleric Acid is used as a reagent in the preparation of indole derivatives which act as cell protective agents. It is also used as a reagent in the catalytic N-nitroso aldol reaction of γ,δ-unsaturated δ-lactones.<br>References Yamamoto, I., et al.: Preparation of indole derivatives as cell protective agents, WO Patent 9745410, Dec 4, 1997; Yanagisawa, A., et al.: Org. Lett., 14, 2434 (2012);<br></p>Formula:C11H11FO3Color and Shape:NeatMolecular weight:210.2OPC 14714
CAS:Controlled Product<p>Impurity Aripiprazole Impurity<br>Applications A novel antipsychotic agents with dopamine autoreceptor agonist properties. Aripiprazole Impurity<br>References Simpson, G., et al.: Drugs, 1981, 21, 138 (1981), Banno, K., et al.: Chem. Pharm. Bull., 36, 4377 (1988), Momiyama, T., et al.: Life Sci., 47, 761 (1990), Caprathe, B., et al.: J. Med. Chem., 34, 2736 (1991),<br></p>Formula:C23H28BrN3O2Color and Shape:White To Off-WhiteMolecular weight:458.39N-(4-Methoxybenzyl)-4-chloro-2-(trifluoroacetyl)aniline
CAS:Controlled ProductFormula:C16H13ClF3NO2Color and Shape:NeatMolecular weight:343.734-Desisopropyl-4-ethyl Nateglinide
CAS:Controlled Product<p>Applications D-phenylanaline derivative and an analog Nateglinide (N379375) with similar hypoglycemic activity.<br>References Shinkai, H. et al.: J. Med. Chem., 32, 1436 (1989);<br></p>Formula:C18H25NO3Color and Shape:NeatMolecular weight:303.40
![4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC370130.webp&w=3840&q=75)
![Ethyl 2-[N-[(2'-Cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FE930618.webp&w=3840&q=75)
![4'-(Bromomethyl)-[1,1'-biphenyl]-2-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB685270.webp&w=3840&q=75)
![N-[(1S,2S,4S)-4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]ca…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD472785.webp&w=3840&q=75)
![Anastrozole EP Impurity E (2-[3-(Cyanodimethylmethyl)-5-hydroxymethylphenyl]-2-methylpropionitrile)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA637428.webp&w=3840&q=75)
![1-Benzo[b]thien-4-yl-piperazine Monohydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB194840.webp&w=3840&q=75)
![1-Ethyl-2-[(methylamino)methyl]pyrrolidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FE923645.webp&w=3840&q=75)
![S-Desethylpiperidino S-[2-Carboxyl-2-oxo-ethyl-(2-aminoethyl)amino] Vardenafil](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD290970.webp&w=3840&q=75)
![Ibrutinib Addition Adduct with (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FI124980.webp&w=3840&q=75)
![N’-[2-[2,4-(Dimethylphenyl)thio]phenyl] Vortioxetine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FD477790.webp&w=3840&q=75)
![5-Methoxy-1-[4-(difluoromethyl)phenyl]-1-pentanone Oxime](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM262550.webp&w=3840&q=75)
![3-[2-[4-(6-Fluoro-2-benzoxazolyl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FF588505.webp&w=3840&q=75)
![N-[3-Methyl-1-(1-phenylcyclobutyl)butyl]-N,N-dimethylamine Hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM326058.webp&w=3840&q=75)
![4-Hydroxy-2-methyl- 1,1-dioxide-2H-thieno[2,3-e]-1,2-thiazine-3-carboxamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FH620485.webp&w=3840&q=75)
![Benzo[b]thien-2-yl Ketone (Zileuton Impurity)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB207710.webp&w=3840&q=75)
![5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Ethyl Ester](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC369650.webp&w=3840&q=75)
![4-[3-(Methylamino)-1-(2-thienyl)propyl]-1-naphthalenol Hydrochloride (Duloxetine Impurity)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM287200.webp&w=3840&q=75)
![3-[(1E)-2-[4-[[(2-Carboxyethyl)amino]carbonyl]phenyl]diazenyl] Balsalazide Sodium Salt (>90%)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC178020.webp&w=3840&q=75)
![2-[[(3aR,4S,6R,6aS)-6-[[5-Amino-6-chloro-2-(propylthio)-4-pyrimidinyl]amino]tetrahydro-2,2-dimethy…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FA604205.webp&w=3840&q=75)
![(1S,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB200020.webp&w=3840&q=75)
![3’-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]propyl Domperidine (Domperid…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC365315.webp&w=3840&q=75)
![[3-(9H-Carbazol-4-yloxy)-2-hydroxy]propyl Carvedilol](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC175950.webp&w=3840&q=75)
![1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Sodium Salt](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB203965.webp&w=3840&q=75)
![(alphaR)-α-Methyl-N-[3-[4-(trifluoromethyl)phenyl]propyl]-1-naphthalenemethanamine Hydrochloride S…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM331083.webp&w=3840&q=75)
![N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FB400600.webp&w=3840&q=75)
![Methyl 4-Methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]benzoate](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FM325060.webp&w=3840&q=75)
![N-Cyano-N’,N”-bis[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]guanidine](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC955230.webp&w=3840&q=75)
![2,2'-[[[4-(3-Oxo-4-morpholinyl)phenyl]imino]bis[(2R)-2-hydroxy-3,1-propanediyl]]b…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FO858058.webp&w=3840&q=75)
